Activation of Apoptosis Pathways by Anticancer Drugs
- 1 January 1999
- book chapter
- Published by Springer Nature
- Vol. 457, 237-244
- https://doi.org/10.1007/978-1-4615-4811-9_25
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Role of the CD40 and CD95 (APO‐1/Fas) antigens in the apoptosis of human B‐cell malignanciesBritish Journal of Haematology, 1997
- Expression of Apo‐1/Fas (CD95), Bcl‐2, Bax and Bcl‐x in myeloma cell lines: relationship between responsiveness to anti‐Fas mab and p53 functional statusBritish Journal of Haematology, 1997
- Expression and function of CD95 (FAS/APO‐1) in leukaemia‐lymphoma tumour linesBritish Journal of Haematology, 1997
- Apoptosis by Death FactorCell, 1997
- Mutations in Fas Associated with Human Lymphoproliferative Syndrome and AutoimmunityScience, 1995
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995
- Expression of the Fas antigen on primary human leukemia cellsAnnals of Hematology, 1995
- The Role of APO‐1‐Mediated Apoptosis in the Immune SystemImmunological Reviews, 1994
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- APO-1 (CD95) and Bcl-2: Determinants of cell death in the human thymusResearch in Immunology, 1994